Legal & General Group
DTIL icon

Legal & General Group’s Precision BioSciences DTIL Stock Holding History

Legal & General Group’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4K Buy
+2,335
New +$16.4K ﹤0.01% 3163
2022
Q4 		– Sell
-146
Closed -$6K – 3423
2022
Q3 		$6K Sell
146
-2,058
-93% -$97.8K ﹤0.01% 3390
2022
Q2 		$106K Buy
2,204
+1,301
+144% +$76.4K ﹤0.01% 2840
2022
Q1 		$83K Hold
903
– – ﹤0.01% 2912
2021
Q4 		$200K Buy
903
+4
+0.4% +$1.12K ﹤0.01% 2724
2021
Q3 		$311K Buy
899
+310
+53% +$105K ﹤0.01% 2557
2021
Q2 		$221K Buy
589
+376
+177% +$113K ﹤0.01% 2511
2021
Q1 		$66K Sell
213
-18
-8% -$6.3K ﹤0.01% 2740
2020
Q4 		$58K Buy
231
+43
+23% +$10.5K ﹤0.01% 2760
2020
Q3 		$35K Sell
188
-59
-24% -$11.7K ﹤0.01% 2797
2020
Q2 		$62K Buy
247
+49
+25% +$10.7K ﹤0.01% 2669
2020
Q1 		$36K Sell
198
-49
-20% -$12.8K ﹤0.01% 2702
2019
Q4 		$103K Buy
247
+197
+394% +$61.9K ﹤0.01% 2583
2019
Q3 		$13K Hold
50
– – ﹤0.01% 3226
2019
Q2 		$20K Sell
50
-83
-62% -$33.4K ﹤0.01% 3191
2019
Q1 		$70K Buy
+133
New +$70.6K ﹤0.01% 2607

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Legal & General Group's DTIL Position: Q2 2026 in Review

Legal & General Group opened a new position in Precision BioSciences (DTIL) in Q2 2026: 2,335 shares worth $18.4K. The stake represents ﹤0.01% of the portfolio and ranks #3163 among its holdings. This is a return to the name: Legal & General Group previously reported a position in DTIL as recently as Q3 2022.

Legal & General Group first reported a position in DTIL in Q1 2019 and has held it in 16 quarters since. The position peaked at $311K in Q3 2021. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Legal & General Group held 2,335 shares of Precision BioSciences worth $18.4K as of Q2 2026.
  • Precision BioSciences was a new Legal & General Group position in Q2 2026.
  • Precision BioSciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3163 holding.
  • Legal & General Group first reported a position in Precision BioSciences in Q1 2019 and has held it in 16 quarters since.
  • Legal & General Group's Precision BioSciences position peaked at $311K in Q3 2021.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.